Exeter Financial’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.58M | Sell |
12,653
-24
| -0.2% | -$8.22K | 1.75% | 20 |
|
|
2026
Q1 | $4.46M | Buy |
12,677
+437
| +4% | +$156K | 1.82% | 20 |
|
|
2025
Q4 | $4.01M | Buy |
12,240
+428
| +4% | +$136K | 1.7% | 20 |
|
|
2025
Q3 | $3.33M | Buy |
11,812
+133
| +1% | +$38.6K | 1.44% | 26 |
|
|
2025
Q2 | $3.26M | Buy |
11,679
+79
| +0.7% | +$22.4K | 1.45% | 24 |
|
|
2025
Q1 | $3.61M | Buy |
11,600
+176
| +2% | +$52K | 1.62% | 22 |
|
|
2024
Q4 | $2.98M | Buy |
11,424
+313
| +3% | +$92.9K | 1.36% | 27 |
|
|
2024
Q3 | $3.58M | Sell |
11,111
-362
| -3% | -$118K | 1.59% | 24 |
|
|
2024
Q2 | $3.58M | Sell |
11,473
-606
| -5% | -$178K | 1.71% | 19 |
|
|
2024
Q1 | $3.24M | Buy |
12,079
+85
| +0.7% | +$24.9K | 1.49% | 24 |
|
|
2023
Q4 | $3.69M | Buy |
11,994
+327
| +3% | +$89.1K | 1.79% | 18 |
|
|
2023
Q3 | $3.14M | Buy |
11,667
+314
| +3% | +$78.4K | 1.66% | 20 |
|
|
2023
Q2 | $2.54M | Buy |
11,353
+1,486
| +15% | +$345K | 1.31% | 31 |
|
|
2023
Q1 | $2.48M | Buy |
9,867
+52
| +0.5% | +$12.8K | 1.24% | 31 |
|
|
2022
Q4 | $2.58M | Sell |
9,815
-47
| -0.5% | -$12.6K | 1.34% | 26 |
|
|
2022
Q3 | $2.22M | Buy |
9,862
+366
| +4% | +$88.7K | 1.29% | 28 |
|
|
2022
Q2 | $2.31M | Buy |
9,496
+272
| +3% | +$66.7K | 1.29% | 30 |
|
|
2022
Q1 | $2.23M | Buy |
9,224
+841
| +10% | +$193K | 1.21% | 32 |
|
|
2021
Q4 | $1.93M | Buy |
8,383
+2,616
| +45% | +$552K | 1.06% | 37 |
|
|
2021
Q3 | $1.23M | Buy |
5,767
+251
| +5% | +$57.8K | 0.73% | 50 |
|
|
2021
Q2 | $1.37M | Buy |
5,516
+1
| +0% | +$246 | 0.8% | 46 |
|
|
2021
Q1 | $1.37M | Buy |
5,515
+126
| +2% | +$30.1K | 0.87% | 46 |
|
|
2020
Q4 | $1.24M | Hold |
5,389
| – | – | 0.86% | 44 |
|
|
2020
Q3 | $1.37M | Hold |
5,389
| – | – | 1.07% | 36 |
|
|
2020
Q2 | $1.27M | Sell |
5,389
-425
| -7% | -$97K | 1.06% | 38 |
|
|
2020
Q1 | $1.18M | Buy |
5,814
+1,050
| +22% | +$229K | 1.11% | 36 |
|
|
2019
Q4 | $1.15M | Sell |
4,764
-250
| -5% | -$55.1K | 0.89% | 45 |
|
|
2019
Q3 | $970K | Hold |
5,014
| – | – | 0.77% | 49 |
|
|
2019
Q2 | $924K | Buy |
5,014
+125
| +3% | +$22.4K | 0.77% | 50 |
|
|
2019
Q1 | $929K | Sell |
4,889
-240
| -5% | -$45.8K | 0.8% | 49 |
|
|
2018
Q4 | $998K | Hold |
5,129
| – | – | 0.94% | 45 |
|
|
2018
Q3 | $1.06M | Hold |
5,129
| – | – | 0.87% | 47 |
|
|
2018
Q2 | $947K | Buy |
5,129
+10
| +0.2% | +$1.77K | 0.83% | 49 |
|
|
2018
Q1 | $873K | Buy |
5,119
+25
| +0.5% | +$4.59K | 0.75% | 52 |
|
|
2017
Q4 | $886K | Buy |
+5,094
| New | +$902K | 0.77% | 49 |
|
Other funds holding AMGN
FFM
SP
Exeter Financial's AMGN Position: Q2 2026 in Review
Exeter Financial reduced its Amgen (AMGN) stake by 0.19% in Q2 2026, selling an estimated $8.22K and leaving 12,653 shares worth $4.58M. The position accounts for 1.75% of the portfolio, ranked #20.
Exeter Financial first reported a position in AMGN in Q4 2017 and has held it in 35 quarters since. 1,264 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Exeter Financial held 12,653 shares of Amgen worth $4.58M as of Q2 2026.
- Exeter Financial sold 24 Amgen shares in Q2 2026, an estimated $8.22K.
- Amgen made up 1.75% of Exeter Financial's portfolio in Q2 2026, its #20 holding.
- Exeter Financial first reported a position in Amgen in Q4 2017 and has held it in 35 quarters since.
- 1,264 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Exeter Financial's 13F filing for Q2 2026, filed 16 Jul 2026.